277 related articles for article (PubMed ID: 19549514)
1. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
[TBL] [Abstract][Full Text] [Related]
2. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
Rogóz Z; Skuza G; Kłlodzińska A
Pol J Pharmacol; 2004; 56(5):519-26. PubMed ID: 15591639
[TBL] [Abstract][Full Text] [Related]
4. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
5. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
[TBL] [Abstract][Full Text] [Related]
6. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
Rogóz Z; Dziedzicka-Wasylewska M
Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
[TBL] [Abstract][Full Text] [Related]
8. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.
Li Y; Zhu ZR; Ou BC; Wang YQ; Tan ZB; Deng CM; Gao YY; Tang M; So JH; Mu YL; Zhang LQ
Behav Brain Res; 2015 Feb; 279():100-5. PubMed ID: 25449845
[TBL] [Abstract][Full Text] [Related]
10. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
Chagas-Martinich L; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
[TBL] [Abstract][Full Text] [Related]
11. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
Maj J; Rogói Z; Margas W; Kata M; Dziedzicka-Wasylewska M
J Neural Transm (Vienna); 2000; 107(12):1369-79. PubMed ID: 11458990
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.
Schulte-Herbrüggen O; Vogt MA; Hörtnagl H; Gass P; Hellweg R
Eur J Pharmacol; 2012 Feb; 677(1-3):77-86. PubMed ID: 22206815
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
14. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
Kitagawa K; Kitamura Y; Miyazaki T; Miyaoka J; Kawasaki H; Asanuma M; Sendo T; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):59-66. PubMed ID: 19274453
[TBL] [Abstract][Full Text] [Related]
15. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors.
Fenu S; Espa E; Pisanu A; Di Chiara G
Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
17. Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.
Takahashi K; Nakagawasai O; Nemoto W; Nakajima T; Arai Y; Hisamitsu T; Tan-No K
Psychopharmacology (Berl); 2016 Apr; 233(7):1311-22. PubMed ID: 26856855
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
19. Some behavioural effects of antidepressant drugs are time-dependent.
Dziedzicka-Wasylewska M; Rogóz Z; Margas W; Dlaboga D; Góralska M
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):373-93. PubMed ID: 11294483
[TBL] [Abstract][Full Text] [Related]
20. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
Breuer ME; Chan JS; Oosting RS; Groenink L; Korte SM; Campbell U; Schreiber R; Hanania T; Snoeren EM; Waldinger M; Olivier B
Eur Neuropsychopharmacol; 2008 Dec; 18(12):908-16. PubMed ID: 18789657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
